GBI Biomanufacturing Partners with NanoRetinal to Advance Vision-Restoring Therapy for Inherited Retinal Diseases
Experience.
History-Making.
GBI Biomanufacturing Announces Sven Lee as New Board Member
miRecule and GBI Biomanufacturing Announce Strategic Partnership to Advance Development of Antibody RNA Conjugate (ARC) Therapies
GBI Biomanufacturing Expands Capabilities with Automated Aseptic Fill-Finish for Drug Products
GBI Biomanufacturing and Allterum Therapeutics Announce Strategic Collaboration to Manufacture Therapeutic Antibody for Clinical Trials
GBI Secures Commercial Manufacturing Contract, Solidifying Leadership in Radiopharmaceutical Manufacturing
Goodwin Biotechnology Inc. (GBI) Announces First Commercial Contract Signing
Goodwin Biotechnology Inc. is now GBI, as Part of their Rebranding Initiative on their 30-Year Anniversary!
Goodwin Biotechnology Announces the Appointment of Darrin T. Schellin as Chief Executive Officer
